Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-12-15
DOI
10.3389/fphar.2017.00607
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer
- (2017) Amit M. Oza et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve
- (2017) Cristina Scavone et al. PHARMACOLOGICAL RESEARCH
- Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis
- (2017) Bruno César da Silva et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
- (2016) Jie Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
- (2016) Tobias Engel Ayer Botrel et al. BMC CANCER
- Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy
- (2016) Monia Donati et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis
- (2016) Stefanos Bonovas et al. Clinical Gastroenterology and Hepatology
- Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch
- (2016) Concetta Rafaniello et al. Expert Opinion On Drug Safety
- Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions
- (2016) Maurizio Sessa et al. Expert Opinion On Drug Safety
- Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs
- (2016) Maurizio Sessa et al. Expert Opinion On Drug Safety
- No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region
- (2016) Liberata Sportiello et al. Expert Opinion On Drug Safety
- The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy
- (2016) Liberata Sportiello et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan
- (2016) Ken Nakajima et al. Modern Rheumatology
- Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system
- (2016) Concetta Rafaniello et al. PHARMACOLOGICAL RESEARCH
- Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer
- (2016) Masahito Kotaka et al. OncoTargets and Therapy
- Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
- (2015) Hubert G. Nüßlein et al. BMC MUSCULOSKELETAL DISORDERS
- Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab
- (2015) B. Yeo et al. BREAST
- Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL
- (2015) Bárbara P. Fafá et al. CLINICAL RHEUMATOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis
- (2015) Chi Chiu Mok et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective
- (2015) Susan Bolge et al. Patient Preference and Adherence
- Bisphosphonate-related osteonecrosis of the jaw: an Italian post-marketing surveillance analysis
- (2014) Elisabetta Parretta et al. Expert Opinion On Drug Safety
- Adverse reactions to biologic agents and their medical management
- (2014) Onur Boyman et al. Nature Reviews Rheumatology
- An Updated Meta-Analysis of Fatal Adverse Events Caused by Bevacizumab Therapy in Cancer Patients
- (2014) Hongxin Huang et al. PLoS One
- Pattern of Statin Use in Southern Italian Primary Care: Can Prescription Databases Be Used for Monitoring Long-Term Adherence to the Treatment?
- (2014) Carmen Ferrajolo et al. PLoS One
- Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
- (2014) Evripidis Kaltsonoudis et al. ARTHRITIS RESEARCH & THERAPY
- Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?
- (2013) Elizabeth Tranter et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical considerations for biosimilar antibodies
- (2013) Håkan Mellstedt EJC SUPPLEMENTS
- Hemoptysis and Acute Respiratory Syndrome (ARDS) as Delayed-Type Hypersensitivity After FOLFOX4 Plus Bevacizumab Treatment
- (2013) Takaaki Kobayashi et al. INTERNATIONAL SURGERY
- Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
- (2013) Pauline A. van Schouwenburg et al. Nature Reviews Rheumatology
- Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy
- (2013) S. Cammarota et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Postmarketing safety of biologics and biological devices
- (2013) Emily Jane Woo Spine Journal
- Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
- (2013) José Miguel Senabre-Gallego et al. Patient Preference and Adherence
- Anti-VEGF Therapies in the Clinic
- (2013) K. L. Meadows et al. Cold Spring Harbor Perspectives in Medicine
- Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses
- (2013) Brian Baldo OncoImmunology
- Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Serious Adverse Events Associated With Biologic and Nonbiologic Psoriasis Systemic Therapy
- (2012) Gregorio Carretero ARCHIVES OF DERMATOLOGY
- Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
- (2012) Armen Yuri Gasparyan et al. CURRENT PHARMACEUTICAL DESIGN
- Rituximab-induced thrombocytopenia: a cohort study
- (2012) Thijs J. Giezen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring Study
- (2012) Simona Ruggiero et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
- (2012) W. Grisold et al. NEURO-ONCOLOGY
- Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial
- (2011) Ian Smith et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of Care
- (2011) Jeffrey R. Curtis et al. CLINICAL THERAPEUTICS
- Haematologic toxicities associated with the addition of bevacizumab in cancer patients
- (2011) Fabio A.B. Schutz et al. EUROPEAN JOURNAL OF CANCER
- Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multicentre, phase IIIb study
- (2011) K. Papp et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer
- (2010) M. Fakih et al. Current Oncology
- Sex disparities in colorectal cancer incidence by anatomic subsite, race and age
- (2010) Gwen Murphy et al. INTERNATIONAL JOURNAL OF CANCER
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Safety and efficacy of etanercept beyond 10 years of therapy in North American patients with early and long-standing rheumatoid arthritis
- (2010) Michael E. Weinblatt et al. ARTHRITIS CARE & RESEARCH
- Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice
- (2010) Gregory P. Hess et al. Journal of Oncology Practice
- Infectious Complications Associated with Monoclonal Antibodies and Related Small Molecules
- (2009) E. M. T. Salvana et al. CLINICAL MICROBIOLOGY REVIEWS
- The Reason for Discontinuation of the First Tumor Necrosis Factor (TNF) Blocking Agent Does Not Influence the Effect of a Second TNF Blocking Agent in Patients with Rheumatoid Arthritis
- (2009) M. BLOM et al. JOURNAL OF RHEUMATOLOGY
- The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
- (2009) Daniel E. Furst SEMINARS IN ARTHRITIS AND RHEUMATISM
- Severe Myalgia Associated with Adalimumab Treatment in a Patient with Crohn's Disease
- (2008) Joaquín Hinojosa et al. ANNALS OF PHARMACOTHERAPY
- Biologics and heart failure in rheumatoid arthritis: are we any wiser?
- (2008) Maria I Danila et al. CURRENT OPINION IN RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More